Investigators have defined the role of a recently identified gene abnormality – rearrangements in the ROS1 gene – in a deadly form of lung cancer. ROS1-rearranged tumors represent one to two percent of non-small-cell lung cancers, the leading cause of cancer death in the US. The researchers also show that ROS1-driven tumors can be treated with crizotinib and describe the remarkable response of ...